Bundibugyo Virus Disease in 2026 — Clinical and Public Health Responses
• The Bundibugyo virus, a rare orthoebolavirus, remains a significant public health threat due to its ability to cause severe epidemic disease with high mortality rates. • While advances in supportive care have improved patient outcomes, there are currently no licensed vaccines or approved therapeutics specifically designed for the Bundibugyo virus. • Research using human serum and nonhuman primates indicates that vaccines developed for the Ebola virus may provide critical cross-protection against this related pathogen.
nejm.org